Anthony Japour
Director/Board Member chez COCRYSTAL PHARMA, INC.
Fortune : - $ au 31/03/2024
Profil
Actuellement, Anthony J. Japour occupe le poste de directeur et propriétaire d'Anthony Japour & Associates Medical & Scientific Consulting In. Il est également membre du conseil d'administration de Cocrystal Pharma, Inc. Dans le passé, le Dr Japour a occupé le poste de directeur médical d'ICON plc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
COCRYSTAL PHARMA INC
-.--% | 10/04/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Anthony Japour
| Sociétés | Poste | Début |
|---|---|---|
| COCRYSTAL PHARMA, INC. | Director/Board Member | 04/04/2019 |
| SANY HEAL | Director/Board Member | - |
| Anthony Japour & Associates Medical & Scientific Consulting In | Director/Board Member | 01/11/2006 |
Itolerance, Inc.
 Itolerance, Inc. BiotechnologyHealth Technology Itolerance, Inc. is an American biotechnology company that specializes in developing regenerative medicines. The private company was founded by Cameron Gray and is currently led by CEO Anthony J. Japour. | Chief Executive Officer | - |
Anciens postes connus de Anthony Japour
| Sociétés | Poste | Fin |
|---|---|---|
| OPKO HEALTH, INC. | Director/Board Member | 25/06/2020 |
| ICON PUBLIC LIMITED COMPANY | Chief Tech/Sci/R&D Officer | 01/04/2020 |
| AdvancedDx Biological Laboratories USA, Inc. | Chief Executive Officer | - |
Formation de Anthony Japour
| Northwestern University | Graduate Degree |
| University of Michigan | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ICON PUBLIC LIMITED COMPANY | Commercial Services |
| OPKO HEALTH, INC. | Health Services |
| COCRYSTAL PHARMA, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
| Anthony Japour & Associates Medical & Scientific Consulting In | |
Sanaby Health Acquisition Corp. I
 Sanaby Health Acquisition Corp. I Financial ConglomeratesFinance Sanaby Health Acquisition Corp. I operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Sandra Shpilberg on April 8, 2021 and is headquartered in Palo Alto, CA. | Finance |
Itolerance, Inc.
Itolerance, Inc. BiotechnologyHealth Technology Itolerance, Inc. is an American biotechnology company that specializes in developing regenerative medicines. The private company was founded by Cameron Gray and is currently led by CEO Anthony J. Japour. | Health Technology |
| AdvancedDx Biological Laboratories USA, Inc. |
